What are the management guidelines for a patient with diabetes mellitus?

Diabetes Mellitus Management Guidelines

Immediate Action at Diagnosis

Start metformin immediately at diagnosis alongside lifestyle interventions unless contraindicated by renal dysfunction (eGFR <30 mL/min/1.73 m²). 1, 2, 3

For patients presenting with marked hyperglycemia (blood glucose ≥250 mg/dL or HbA1c ≥8.5%) who are symptomatic, initiate basal insulin concurrently with metformin. 3

---

Initial Evaluation Requirements

Perform these specific assessments at diagnosis:

• Laboratory panel: HbA1c, fasting glucose, complete lipid profile (LDL, HDL, triglycerides), serum creatinine with eGFR calculation, and urine albumin-to-creatinine ratio 1, 3
• Cardiovascular risk stratification: Blood pressure measurement, assessment for existing cardiovascular disease, calculation of 10-year cardiovascular risk 1, 2
• Complication screening: Comprehensive dilated eye examination, comprehensive foot examination including monofilament testing and vibration sensation, assessment for peripheral neuropathy 1, 2, 3
• Type 1 diabetes specific: Screen for thyroid dysfunction (TSH) and celiac disease (tissue transglutaminase antibodies) 1, 2

---

Glycemic Targets

Set HbA1c target ranges (not single values) based on this algorithm: 4

• Most adults without significant comorbidities: HbA1c 7.0-8.0% 4
• Older adults with multiple comorbidities, limited life expectancy, or high hypoglycemia risk: HbA1c 8.0-9.0% 4
• Younger patients with long life expectancy and low hypoglycemia risk: HbA1c 6.5-7.0% 4

Reassess HbA1c every 3 months until target is achieved, then every 3-6 months. 1, 3

---

Lifestyle Interventions (Non-Negotiable First-Line)

Weight Loss Protocol

• Prescribe 500-750 kcal/day energy deficit targeting ≥5% weight loss 1, 2, 3
• Any of these dietary patterns are equally effective: Mediterranean, DASH, plant-based, lower-carbohydrate, or lower-fat diets 1, 2
• Critical point: Weight loss of 5-10% has been proven to reduce diabetes incidence in at-risk populations 4, 5

Physical Activity Prescription

• Aerobic activity: 150 minutes per week of moderate-intensity exercise (50-70% maximum heart rate), spread over at least 3 days with no more than 2 consecutive days without exercise 4, 2
• Resistance training: At least twice weekly 4, 2
• Reduce sedentary time throughout the day 2, 6

Medical Nutrition Therapy

• Refer to registered dietitian for individualized meal planning 1, 2
• No single ideal macronutrient distribution exists; base on individual assessment and preferences 1, 2
• Limit alcohol to ≤1 drink/day for women, ≤2 drinks/day for men, with precautions against hypoglycemia 4

---

Pharmacologic Therapy Algorithm

Step 1: Metformin Monotherapy

• Start metformin as first-line agent if eGFR >30 mL/min/1.73 m² 4, 1, 2, 3
• Titrate to maximum tolerated dose 4

Step 2: Add Second Agent if HbA1c Not at Target After 3 Months

Select based on these patient characteristics: 4

If established cardiovascular disease or high cardiovascular risk:

• Add GLP-1 agonist (liraglutide) OR SGLT2 inhibitor (empagliflozin) - both have proven cardiovascular mortality benefit 4

If primary concern is hypoglycemia avoidance:

• Add DPP-4 inhibitor or GLP-1 agonist 4

If weight loss is priority:

• Add GLP-1 agonist 4

If cost is primary barrier:

• Add sulfonylurea (accept higher hypoglycemia risk) 4

Step 3: Triple Therapy or Insulin

• Add third oral agent from different class OR initiate basal insulin 4, 2
• When adding insulin to oral agents, continue metformin 2

---

Cardiovascular Risk Management (Mandatory)

Blood Pressure Targets

• Target <140/90 mmHg for most patients 1, 2
• Target <130/80 mmHg if chronic kidney disease or high cardiovascular risk 1
• First-line agents: ACE inhibitor or ARB (never both simultaneously) 2

Lipid Management

• Initiate statin therapy for all patients ≥40 years old 2
• Statin intensity based on cardiovascular risk stratification 2
• Lifestyle modification includes reducing saturated fat, trans fat, and cholesterol 2

---

Diabetes Self-Management Education (DSME)

Provide structured education at these critical timepoints: 1, 2, 3

• At diagnosis 1, 2
• When not meeting treatment targets 1
• When complications develop 1
• During transitions in care 1

Essential education content:

• Hypoglycemia recognition and treatment: 15-20g rapid-acting glucose, recheck in 15 minutes, repeat if needed 4, 2
• Medication administration technique 1, 2
• Blood glucose monitoring technique and interpretation 1, 2
• Sick day management 2

---

Hypoglycemia Management Protocol

• Conscious patient: Give 15-20g glucose (preferred) or any carbohydrate containing glucose 4, 2
• Recheck blood glucose in 15 minutes; repeat treatment if still low 4
• Once normalized, consume meal/snack to prevent recurrence 4
• Severe hypoglycemia: Prescribe glucagon for all patients at significant risk; train family members in administration 4
• Hypoglycemia unawareness: Raise glycemic targets for several weeks to restore awareness 4

---

Complication Screening Schedule

Annual Requirements

• Comprehensive dilated eye examination 1, 2, 3
• Urine albumin-to-creatinine ratio 1, 3
• Serum creatinine with eGFR calculation 1, 3
• Comprehensive foot examination 1, 2, 3
• Lipid profile 1

Age-Appropriate Vaccinations

• Influenza vaccine annually 1, 2, 3
• Pneumococcal vaccine per CDC guidelines 1, 2, 3
• Hepatitis B vaccine series 1, 2, 3

---

Team-Based Care Structure

Assemble multidisciplinary team including: 1, 2, 3

• Primary care physician or endocrinologist 1, 2
• Nurse practitioner or physician assistant 1, 2
• Registered dietitian 1, 2
• Certified diabetes educator 1, 2
• Pharmacist for medication management 1, 2
• Mental health professional for screening depression, anxiety, eating disorders 4, 1, 2
• Podiatrist for high-risk foot conditions 2

---

Bariatric Surgery Consideration

Consider bariatric surgery for patients with: 4

• BMI >35 kg/m² AND type 2 diabetes 4
• Diabetes or comorbidities difficult to control with lifestyle and pharmacologic therapy 4
• Post-surgery: Lifelong lifestyle support and medical monitoring required 4

---

Inpatient Glycemic Management

For critically ill hospitalized patients, target blood glucose <180 mg/dL rather than tight control (80-110 mg/dL). 4

The lower target range increases hypoglycemia risk 14-fold and increases mortality. 4

---

Common Pitfalls to Avoid

• Clinical inertia: Waiting >3 months to intensify therapy when HbA1c remains above target 1, 3
• Overtreatment in elderly: Pursuing HbA1c <7% in patients with limited life expectancy or high hypoglycemia risk 4
• Ignoring cardiovascular medications: Failing to initiate statin and ACE inhibitor/ARB when indicated 2
• Neglecting DSME: Prescribing medications without ensuring patient understands administration and monitoring 1, 2
• Monotherapy persistence: Continuing single agent beyond 3 months when not achieving glycemic targets 4, 3